UNSPSC 51171726: Zaldaride maleate

This classification denotes an antidiarrheal agent with the molecular formula C26H28N4O2.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K7SG01P7NJ, chemically known as 1,3-dihydro-1-(1-((4-methyl-4h,6h-pyrrolo(1,2-a)(4,1)benzoxazepin-4-yl)methyl)-4-piperidinyl)-2h-benzimidazol-2-one maleate, but more generally known as zaldaride maleate, which bears US NIH Compound Identifier 6450522.

European Medicines Agency schedules zaldaride maleate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00131MIG. Most nations, for tariff purposes, schedule zaldaride maleate under HS 29349990. SMILES: CC1(C2CCCN2-C3CCCCC3CO1)CN4CCC(CC4)N5C6CCCCC6[NH]C5=O.C(=C\C(=O)O)\C(=O)O.

UNSPSC 51171726 Zaldaride maleate is a Commodity code that classifies a specific pharmaceutical agent, but the recent state and local procurement activity tagged under this code does not involve zaldaride maleate itself. Collin County Community Supervision and Corrections Department posted RFP 2026-327 on September 25, 2026 for offender specimen collection and drug testing services—a scope that encompasses staffing collection sites, operating randomized-testing systems, conducting immunoassay screening with confirmatory analysis (LC/MS/MS or GC/MS), and providing alternative testing methodologies including oral fluid and hair analysis. The contract does not name zaldaride maleate as a reagent, test subject, or consumable; the actual scope centers on testing infrastructure and labor rather than on a specific pharmaceutical commodity. The issuing body is a county-level criminal-justice department operating under state appropriations.

The geographic activity is limited to Texas, specifically Collin County (with collection sites in Plano and McKinney). Collin County Community Supervision and Corrections Department is the sole recent issuer under this code. RFP 2026-327 carries an estimated contract value of $600,000 over an initial two-year term with three optional one-year renewals, with proposals due July 23, 2026 at 2:00 p.m. and an anticipated award date of August 10, 2026. Evaluation weighs vendor understanding (30 points), firm qualifications (25 points), client references (15 points), and cost (30 points), with optional Phase 2 demonstrations worth up to 30 additional points. The county may award in whole or in part to multiple vendors. The code shows little relevant recent activity tied to the actual pharmaceutical commodity; the opportunity mismatch suggests this code may see minimal state and local procurement volume or that tagging errors have misaligned opportunities with the code's nominal scope.